HDFC Life Insurance Company Ltd
HDFC Life Insurance Company Ltd
Insurance F&OKey Fundamentals
LargecapLife InsuranceInsuranceInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view HDFC Life Insurance Company Ltd insights
36 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
1- Company has been maintaining a healthy dividend payout of 25.3%
Weaknesses
5- Stock is trading at 6.00 times its book value
- The company has delivered a poor sales growth of 6.81% over past five years.
- Tax rate seems low
- Company has a low return on equity of 11.1% over last 3 years.
- Earnings include an other income of Rs.931 Cr.
Growth Rate
AI Analysis — Bull vs Bear
HDFC Life Insurance trades at a market cap of ₹1.17 lakh crore with a PE of 58.9x and P/B of 5.94x. The company delivered 18% individual APE growth and 13% VNB growth in FY25 with a solvency ratio of 194%, but its stock has declined 26% over the past year and ROE remains modest at 11%.
- Individual APE grew 18% YoY in FY25 with Q1 FY26 sustaining 12.5% growth and a 2-year CAGR of 21%, indicating strong new business momentum
- Value of New Business (VNB) grew 13% in FY25 to ₹3,960 crore, with Q1 FY26 VNB at ₹809 crore growing 12.7% YoY
- Market share increased 70 bps to 12.1% at the overall level and 40 bps within private sector to 17.5% in Q1 FY26, demonstrating competitive gains
- Solvency ratio stands at 194% as of March 2025, well above the regulatory minimum of 150%, providing a comfortable capital buffer
- AUM grew 15% YoY to ₹3,362.8 billion in FY25 and Embedded Value (IEV) reached ₹554 billion with Embedded Value Operating Profit (EVOP) of 16.7%
- 13th month persistency ratio stable at 87% and claim settlement ratio at 99.8% in FY25, reflecting strong policyholder retention and operational quality
- Company maintains a consistent dividend payout ratio of 25.3%, providing regular shareholder returns despite moderate yield of 0.39%
- Compounded profit growth of 12% over 3 years and PAT growth of 14% in Q1 FY26 show improving profitability trajectory
- Stock trades at 5.94x book value, significantly expensive for a company delivering only 11% ROE over the last 3 years
- PE ratio of 58.9x is steep, demanding sustained high growth that may be difficult to maintain given 5-year sales CAGR of only 7%
- Stock price has declined 26% over 1 year and shows negative 5-year CAGR of -4%, indicating persistent derating by the market
- New business margin (NBM) contracted from 26.3% in FY24 to 25.6% in FY25, suggesting product mix shift or competitive pressure on profitability
- Total expense ratio increased from 19.4% in FY24 to 19.8% in FY25, indicating rising cost pressures in distribution and operations
- Earnings include other income of ₹931 crore, which inflates reported profits and may not be sustainable or recurring
- 5-year compounded sales growth of just 7% and profit growth of 7% suggest the company's rapid growth phase from 2014-2019 (19% revenue CAGR over 10 years) has moderated significantly
- TTM revenue growth has decelerated to just 4%, significantly below the insurance sector's structural growth opportunity in underpenetrated India
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Q1FY27 net profit up 12% Jul 22
Net profit rose 12% to ₹611.42 crore in Q1FY27, with total premium growing 15% to ₹17,166 crore and VNB up 9% to ₹879 crore. Solvency ratio healthy at 185%.
- Targets stable 25% NBM by FY27 Jul 16
HDFC Life targets growth at or above industry pace by FY27 with new business margins improving to ~25% from 24.20%, 13-month persistency rising to 84-85%, and 19% credit protect growth.
- ₹2.10 dividend approved at AGM Jul 17
HDFC Life approved a final dividend of ₹2.10 per share for FY26 at its 26th AGM, with all resolutions passed.
- Multiple large block trades Aug 5
Block trades totalling ~₹136 crore across NSE and BSE between Jul 13 and Aug 5, with prices ranging from ₹539.85 to ₹571 per share, indicating significant institutional activity.
- Three investor meets in August Aug 4
HDFC Life will participate in Emkay, Motilal Oswal, and Morgan Stanley investor events in August 2026.
- Independent director Bose exits Jul 15
Sumit Bose ceased as independent director on July 18, 2026, upon completing two consecutive five-year terms.
TL;DR: HDFC Life is delivering steady earnings growth with Q1FY27 profit up 12% and premium growth of 15%, supported by improving margins and persistency targets. No material headwinds are visible in recent news flow. Institutional block trades suggest active portfolio rebalancing rather than directional selling. The outlook is constructive with management guiding for industry-matching or better growth and margin expansion into FY27.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23,371 | 23,142 | 26,927 | 28,041 | 26,934 | 28,497 | 17,300 | 24,191 | 29,463 | 20,651 | 29,428 | 19,890 | 33,759 |
| Expenses | 23,045 | 23,557 | 26,663 | 27,766 | 26,623 | 28,807 | 16,852 | 23,814 | 29,024 | 20,336 | 29,157 | 19,782 | 33,253 |
| Operating Profit | 326 | -415 | 264 | 275 | 311 | -310 | 448 | 377 | 439 | 315 | 271 | 108 | 506 |
| OPM % | 1.4% | -1.8% | 1% | 1% | 1.2% | -1.1% | 2.6% | 1.6% | 1.5% | 1.5% | 0.9% | 0.6% | 1.5% |
| Other Income | 114 | 136 | 103 | 174 | 90 | 279 | -29 | 124 | 164 | 157 | 174 | 428 | 171 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 440 | -279 | 367 | 450 | 401 | -30 | 419 | 500 | 604 | 471 | 445 | 537 | 677 |
| Tax % | 5% | -235% | 0% | 8% | -20% | -1541% | -1% | 5% | 9% | 5% | 6% | 7% | 10% |
| Net Profit | 417 | 378 | 368 | 412 | 479 | 435 | 421 | 475 | 548 | 448 | 418 | 497 | 611 |
| EPS in Rs | 1.94 | 1.76 | 1.71 | 1.91 | 2.23 | 2.02 | 1.96 | 2.21 | 2.54 | 2.08 | 1.94 | 2.31 | 2.81 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 27,215 | 18,141 | 30,647 | 32,260 | 38,855 | 29,380 | 71,528 | 67,126 | 70,207 | 1,01,482 | 96,922 | 99,432 | 1,03,727 |
| Expenses | 26,341 | 17,187 | 29,674 | 31,186 | 37,640 | 28,239 | 70,294 | 66,348 | 70,127 | 1,00,836 | 95,894 | 97,679 | 1,02,527 |
| Operating Profit | 874 | 953 | 972 | 1,074 | 1,215 | 1,141 | 1,235 | 778 | 80 | 646 | 1,028 | 1,753 | 1,200 |
| OPM % | 3.2% | 5% | 3.2% | 3.3% | 3.1% | 3.9% | 1.7% | 1.2% | 0.1% | 0.6% | 1.1% | 1.8% | 1.2% |
| Other Income | 79 | 108 | 139 | 282 | 136 | 369 | 445 | 766 | 1,437 | 410 | 366 | 465 | 931 |
| Interest | -14 | 8 | 9 | 11 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 43 | 45 | 41 | 44 | 45 | 47 | 51 | 56 | 76 | 79 | 104 | 161 | 0 |
| PBT | 924 | 1,008 | 1,061 | 1,300 | 1,291 | 1,463 | 1,629 | 1,487 | 1,441 | 977 | 1,290 | 2,057 | 2,130 |
| Tax % | 15% | 19% | 16% | 15% | 1% | 11% | 16% | 11% | 5% | -61% | -40% | 7% | — |
| Net Profit | 786 | 817 | 887 | 1,107 | 1,278 | 1,297 | 1,361 | 1,327 | 1,368 | 1,574 | 1,811 | 1,912 | 1,975 |
| EPS in Rs | 3.94 | 4.09 | 4.44 | 5.5 | 6.33 | 6.43 | 6.73 | 6.28 | 6.37 | 7.32 | 8.41 | 8.86 | 9.14 |
| Div. Payout % | 18% | 22% | 25% | 25% | 26% | 0% | 30% | 27% | 30% | 27% | 25% | 24% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1,995 | 1,995 | 1,998 | 2,012 | 2,017 | 2,019 | 2,021 | 2,113 | 2,149 | 2,151 | 2,153 | 2,158 |
| Reserves | 546 | 1,108 | 1,828 | 2,693 | 3,625 | 4,788 | 6,619 | 13,501 | 10,844 | 12,515 | 14,002 | 15,592 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 600 | 600 | 950 | 950 | 2,950 | 3,099 |
| Other Liabilities | 66,767 | 73,441 | 91,270 | 1,05,778 | 1,24,378 | 1,25,417 | 1,70,415 | 2,14,521 | 2,34,126 | 2,87,071 | 3,30,307 | 3,69,654 |
| Total Liabilities | 69,309 | 76,544 | 95,097 | 1,10,483 | 1,30,020 | 1,32,224 | 1,79,655 | 2,30,734 | 2,48,069 | 3,02,687 | 3,49,412 | 3,90,502 |
| Fixed Assets | 346 | 335 | 337 | 336 | 370 | 322 | 585 | 6,605 | 997 | 1,549 | 2,143 | 2,716 |
| CWIP | 6 | 12 | 16 | 5 | 10 | 8 | 14 | 20 | 31 | 28 | 109 | 139 |
| Investments | 67,024 | 74,144 | 91,723 | 1,06,590 | 1,24,958 | 1,27,256 | 1,73,564 | 2,16,551 | 2,38,197 | 2,91,128 | 3,34,756 | 3,73,340 |
| Other Assets | 1,932 | 2,053 | 3,020 | 3,551 | 4,682 | 4,637 | 5,493 | 7,559 | 8,844 | 9,982 | 12,404 | 14,308 |
| Total Assets | 69,309 | 76,544 | 95,097 | 1,10,483 | 1,30,020 | 1,32,224 | 1,79,655 | 2,30,734 | 2,48,069 | 3,02,687 | 3,49,412 | 3,90,502 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 4,459 | 5,687 | 6,230 | 6,739 | 9,868 | 7,388 | 9,703 | 5,943 | 6,883 | 10,721 | 15,597 | 22,625 |
| Investing | -3,514 | -3,962 | -5,177 | -4,421 | -10,182 | -7,789 | -8,952 | -801 | -10,071 | -13,622 | -13,633 | -23,849 |
| Financing | -168 | -212 | -236 | -196 | -337 | 38 | 678 | -238 | 1,985 | -403 | 1,607 | -275 |
| Net Cash Flow | 777 | 1,513 | 817 | 2,122 | -651 | -364 | 1,429 | 4,904 | -1,203 | -3,304 | 3,572 | -1,499 |
| Free Cash Flow | 4,352 | 5,654 | 6,183 | 6,706 | 9,825 | 7,351 | 9,643 | 5,887 | 6,797 | 10,587 | 15,300 | 22,341 |
| CFO/OP | 510 | 597 | 641 | 627 | 813 | 672 | 806 | 789 | 9,190 | 1,444 | 1,543 | 1,302 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | -11 | -27 | -20 | -25 | -16 | -17 | -13 | -11 | -12 | -8 | -6 | -6 |
| ROCE % | 41% | 36% | 31% | 31% | 23% | 24% | 20% | 12% | 10% | 5% | 7% | 10% |
Documents
Frequently Asked Questions about HDFC Life Insurance Company Ltd
What does HDFC Life Insurance Company Ltd do?
Where is HDFC Life Insurance Company Ltd (HDFCLIFE) listed?
Which sector does HDFC Life Insurance Company Ltd belong to?
What is the market capitalisation of HDFC Life Insurance Company Ltd?
What is the PE ratio of HDFC Life Insurance Company Ltd?
What is the 52-week high and low of HDFC Life Insurance Company Ltd?
Does HDFC Life Insurance Company Ltd pay dividends?
What is the Return on Equity (ROE) of HDFC Life Insurance Company Ltd?
How can I research HDFC Life Insurance Company Ltd on Tapetide?
Company Information
HDFC Life Insurance Company is engaged in carrying on the business of life insurance. The Company offers a range of individual and group insurance solutions. The portfolio comprises of various insurance and investment products such as Protection, Pension, Savings,(Source : 202003 Annual Report Page No: 175)